Dupixent approved for chronic rhinosinusitis with nasal polyps
Dupixent (dupilumab) has been approved to treat nasal polyps in adults with chronic rhinosinusitis, the U.S. Food and Drug Administration announced today.
Jun 27, 2019
0
0
Dupixent (dupilumab) has been approved to treat nasal polyps in adults with chronic rhinosinusitis, the U.S. Food and Drug Administration announced today.
Jun 27, 2019
0
0
(HealthDay)—Chronic rhinosinusitis (CRS) is associated with incidence of depression and anxiety, according to a study published online Feb. 7 in JAMA Otolaryngology-Head & Neck Surgery.
Feb 8, 2019
1
10
Chronic rhinosinusitis (CRS) is a common disease that is usually treated with intranasal medication and nasal saline lavage. Endoscopic sinus surgery (ESS) is considered when CRS is difficult to treat. The surgery aims to ...
Oct 22, 2018
0
0
Chronic rhinosinusitis is distinct from your average case of seasonal allergies. It causes the sinuses to become inflamed and swollen for months to years at a time, leading to difficulty breathing and other symptoms that ...
Aug 22, 2018
0
52
(HealthDay)—The addition of budesonide to a saline nasal lavage for the treatment of chronic rhinosinusitis provides clinically meaningful benefits, according to a study published online June 7 in JAMA Otolaryngology-Head ...
Jul 9, 2018
0
1
Sinus surgeons with The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann-Texas Medical Center are the first in the United States to use augmented reality technology during minimally invasive ...
Mar 13, 2018
0
9
(HealthDay)—Chronic rhinosinusitis (CRS) is associated with increased risk for cholesteatoma, according to a study published online May 11 in JAMA Otolaryngology-Head & Neck Surgery.
May 15, 2017
0
0
(HealthDay)—For patients with asthma, serum periostin is useful for detecting chronic rhinosinusitis with nasal polyps, according to a study published online March 1 in the Annals of the American Thoracic Society.
Mar 21, 2017
0
0
(HealthDay)—For patients with chronic rhinosinusitis with nasal polyps (CRSwNP), the first-generation inhibitor of epithelial P-glycoprotein (P-gp; an efflux pump that is overexpressed in CRSwNP), verapamil hydrochloride ...
Jan 26, 2017
0
1
A clinical trial studying the use of Verapamil (a drug currently in use for cardiovascular disease and cluster headache) in alleviating chronic rhinosinusitis (CRS) with nasal polyps revealed significant improvement in the ...
Jan 23, 2017
0
263